eXoZymes, Inc.
EXOZ
$9.70
$0.394.19%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 26.85% | 1.68% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 30.62% | -1.64% | |||
| Operating Income | -30.62% | 1.64% | |||
| Income Before Tax | -27.14% | -1.00% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -27.14% | -1.11% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -27.14% | -1.11% | |||
| EBIT | -30.62% | 1.64% | |||
| EBITDA | -31.68% | 1.85% | |||
| EPS Basic | -26.95% | 9.35% | |||
| Normalized Basic EPS | -26.96% | 9.46% | |||
| EPS Diluted | -26.95% | 9.35% | |||
| Normalized Diluted EPS | -26.96% | 9.46% | |||
| Average Basic Shares Outstanding | 0.11% | 11.58% | |||
| Average Diluted Shares Outstanding | 0.11% | 11.58% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||